17 November 2022 – Cube Labs, the first venture builder in the healthcare technology space in Italy, announced today that it has extended its strategic partnership with the Italian National Institute for Biostructures and Biosystems (INBB), the leading interuniversity consortium in Italy, for exclusive access to commercial opportunities.  The announcement was made on the occasion of the 14th National Convention of the INBB titled “Research and Innovation for the Environment, Health and Nutrition”, held in Rome at the CNR headquarters, where Cube Labs Founder and CEO, Filippo Surace, and INBB Director, Pietro Ragni, co-chaired the “Technology Transfer and Spin Off” panel.

In 2017, Cube Labs and INBB had entered a 5-year partnership agreement, granting Cube Labs the right of first refusal to commercially promising technologies under development at INBB member universities, leading to the creation of academic spin offs in a public-private technology transfer model. Indeed, the agreement provides Cube Labs with access to valuable commercial opportunities and ensures close and direct contact with INBB researchers. The agreement has now been extended to 2025 and will enable Cube Labs’ exclusive access to an untapped deal flow.

“We are very pleased to have extended this important partnership with INBB as we firmly believe in the value of bringing scientific innovation from the bench to the market,” commented Surace. “We look forward to continuing our joint effort, including through the raising of capital, to transform pioneering research into healthcare solutions that meet the needs of the global market.”

“Our partnership with Cube Labs enables promising INBB research to advance into commercial development,” stated Ragni. “This important link in the innovation value chain is integral to our mission and commitment to support INBB research.”

About Cube Labs

Cube Labs is the first venture builder in the healthcare technology space in Italy, designed to address the gap between the excellent local academic science and the commercially promising life sciences market. Cube Labs builds new companies from promising R&D and enables innovation in order to transform pioneering science into healthcare solutions. Through its international network, Cube Labs works together with communities interested in innovation to transform outcomes for patients and accelerate the world’s transition to optimal health.

About INBB

The Interuniversity Consortium “Istituto Nazionale Biostrutture e Biosistemi” (INBB – Biostructures and Biosystems National Institute) promotes and coordinates research collaborations and other scientific activities between partner universities, and fosters partnerships between universities and the private sector. The consortium is currently composed of 24 public universities, with over 690 researchers working in the areas of Biomolecules, Bioinstrumentation and Bioelectronics, Biosystems and Bioregulations Biotechnology, Biological Supramolecular Functional Unit and Cells.